Stock Buzzer: What Will Happen to Humana Inc Next? The Stock Just Reaches 52-Week High

Stock Buzzer: What Will Happen to Humana Inc Next? The Stock Just Reaches 52 Week High

The stock of Humana Inc (NYSE:HUM) hit a new 52-week high and has $311.66 target or 61.00% above today’s $193.58 share price. The 5 months bullish chart indicates low risk for the $29.93 billion company. The 1-year high was reported on Nov, 11 by If the $311.66 price target is reached, the company will be worth $18.26 billion more.
The 52-week high event is an important milestone for every stock because it shows very positive momentum and is time when buyers come in. During such notable technical setup, fundamental investors usually stay away and are careful shorting or selling the stock. About 2.61M shares traded hands or 94.78% up from the average. Humana Inc (NYSE:HUM) has risen 15.18% since April 11, 2016 and is uptrending. It has outperformed by 9.03% the S&P500.

Humana Inc (NYSE:HUM) Ratings Coverage

Out of 7 analysts covering Humana (NYSE:HUM), 4 rate it a “Buy”, 0 “Sell”, while 3 “Hold”. This means 57% are positive. Humana has been the topic of 17 analyst reports since July 30, 2015 according to StockzIntelligence Inc. Credit Suisse upgraded the shares of HUM in a report on Friday, November 11 to “Outperform” rating. RBC Capital Markets maintained the stock with “Outperform” rating in Friday, July 22 report. The firm earned “Overweight” rating on Thursday, November 10 by JP Morgan. The firm has “Overweight” rating by JP Morgan given on Wednesday, September 16. The rating was maintained by Credit Suisse with “Neutral” on Tuesday, August 16. The firm has “Sector Perform” rating given on Tuesday, September 8 by RBC Capital Markets. The stock of Humana Inc (NYSE:HUM) earned “Neutral” rating by JP Morgan on Friday, July 8. Jefferies maintained Humana Inc (NYSE:HUM) rating on Thursday, August 4. Jefferies has “Buy” rating and $217 price target. The firm has “Mkt Perform” rating given on Friday, July 22 by FBR Capital. The firm earned “Buy” rating on Monday, July 18 by Jefferies.

According to Zacks Investment Research, “Humana, Inc. is a health services company that facilitates the delivery of health care services through networks of providers to its medical members. The company’s products are marketed primarily through health maintenance organizations and preferred provider organizations that encourage or require the use of contracted providers. The company also offers various specialty products to employers, including dental, group life and workers’ compensation, and administrative services to those who self-insure their employee health plans.”

Insitutional Activity: The institutional sentiment increased to 1.1 in Q2 2016. Its up 0.10, from 1 in 2016Q1. The ratio increased, as 43 funds sold all Humana Inc shares owned while 172 reduced positions. 59 funds bought stakes while 178 increased positions. They now own 135.64 million shares or 4.91% less from 142.65 million shares in 2016Q1.
Sfmg Lc accumulated 0.07% or 1,723 shares. Creative Planning last reported 6,555 shares in the company. Gamco Investors Et Al last reported 27,070 shares in the company. New York State Common Retirement Fund accumulated 389,000 shares or 0.1% of the stock. Wexford Capital Ltd Partnership owns 5,238 shares or 0.16% of their US portfolio. Highland Capital Mngmt L P reported 51,700 shares or 0.39% of all its holdings. Para Advisors Lc holds 4.74% or 5,000 shares in its portfolio. Louisiana State Employees Retirement holds 0.09% of its portfolio in Humana Inc (NYSE:HUM) for 9,800 shares. Amf Pensionsforsakring Ab last reported 0.06% of its portfolio in the stock. Baker Ellis Asset Mngmt Limited Liability Corp reported 2,690 shares or 0.15% of all its holdings. The Kentucky-based Argi Invest Ltd has invested 0.1% in Humana Inc (NYSE:HUM). Waddell & Reed Fincl Incorporated holds 88,300 shares or 0.03% of its portfolio. Mitsubishi Ufj Tru And Banking reported 298,478 shares or 0.12% of all its holdings. Zurcher Kantonalbank (Zurich Cantonalbank) last reported 24,921 shares in the company. Scotia Cap accumulated 1,700 shares or 0.01% of the stock.

More recent Humana Inc (NYSE:HUM) news were published by: which released: “Analyst Upgrades: TASER International, Inc., Shake Shack Inc, and Humana Inc” on November 10, 2016. Also published the news titled: “SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation …” on October 14, 2016.‘s news article titled: “SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of …” with publication date: October 13, 2016 was also an interesting one.

HUM Company Profile

Humana Inc. (Humana), incorporated on July 27, 1964, is a health and well-being company. The Company’s medical and specialty insurance products allow members to access healthcare services primarily through its networks of healthcare providers. The Company’s divisions include Retail, Group, Healthcare Services and Other Businesses. The Retail segment consists of Medicare benefits, marketed to individuals or directly via group accounts, as well as individual commercial fully-insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products. The Group segment consists of employer group commercial fully-insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and voluntary insurance benefits, as well as administrative services only (ASO) products. The Healthcare Services segment includes services offered to its health plan members, as well as to third parties, including pharmacy solutions, well-known provider services, home services and clinical programs, as well as services and capabilities to advance population health. The Other Businesses segment includes its closed-block long-term care insurance policies.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Tags: , ,

Related posts

Leave a Comment